| 查看: 1669 | 回复: 7 | |||
| 【有奖交流】积极回复本帖子，参与交流，就有机会分得作者 vnyh3993 的 4 个金币 ，回帖就立即获得 1 个金币，每人有 1 次机会 | |||
[交流]
IgY-Technology英文专著在Springer出版
|
|||
|
IgY-Technology: Production and Application of Egg Yolk Antibodies: Basic Knowledge for a Successful Practice, Springer Nature Group, Switzerland 近日，IgY抗体技术专著（IgY-Technology: Production and Application of Egg Yolk Antibodies: Basic Knowledge for a Successful Practice, Springer Nature Group, Switzerland. 2021. ISBN: 978-3-030-72686-7. https://www.springer.com/gp/book/9783030726867#aboutBook）在Springer出版社出版，该书是全球范围内第一部针对IgY抗体技术的系统性英文学术专著，由张小莺教授领衔主编，联合近二十个国家的四十多位学者历时多年编撰而成。 专著链接：https://www.springer.com/gp/book/9783030726867 该专著共18章，系统性的回顾和总结了IgY抗体技术的发展历程、技术特点和发展前沿，涉及理论基础、技术方法学及生物医药领域的研发应用。专著覆盖了IgY技术相关的各个领域，如进化视野下的IgY分子机制、受体与转运机制、免疫技术、IgY抗体的不同提取纯化策略、储存稳定性、工业化生产、在人类和兽医领域中的应用、IgY递送策略、IgY基因工程抗体制备、转基因动物开发、IgY产品报批及产业化，技术局限与创新等。 近年来，IgY抗体技术（卵黄抗体技术）不断发展，具备了相对完备统一的技术模式；不断与现代生物学技术相结合，拓展技术自生的内涵和外延；相关产品在世界范围内不断报批问世，形成了一定的产业基础。 据悉，科学出版社将与张小莺教授团队合作，在2011年中文版的基础上，适时推出IgY抗体技术中文第二版，以供中国读者和研究人员参考、交流。 图书信息 This first edited Volume on IgY-Technology, addresses the historical and dynamic development of IgY-applications. The authors cover the biological basis and theoretical context, methodological guidance, and applications of IgY-Technology. A focus is laid on the use of IgY-antibodies for prophylactic/therapeutic purposes in human and veterinary medicine. Aside from applications, the chapters also offer an evolutionary understanding of the IgY molecule, IgY receptors and practical prerequisites to produce IgY-antibodies. Guidance is given for every step of the process. Starting with an introduction to hens as a model species and including hen husbandry, hen egg-laying capacity and total IgY outcomes. Readers will also learn about immunization techniques, the advantages and limitations of different IgY extraction methods, as well as storage stability of the final product. The last part of the volume highlights hands-on aspects of applications, such as IgY delivery strategies, new methods to produce monoclonal IgY-antibodies or production of functional IgY fragments by phage-display as well as commercial exploitation of the technology. Thus, this book is a valuable resource and guide for Scientists, Clinicians and Health Product Developers in both human and veterinary medicine. 主编信息 Prof. Dr. Xiaoying ZHANG, PhD in Pharmacology (Charité Medical University Berlin), Distinguished Professor at Shaanxi Univ. of Technology (2019-present); Senior Researcher at CBMA, Univ. of Minho, Portugal (2016-present); Professor (Adjunct) at Univ. of Guelph, Canada (2017-present); Professor at Northwest Agricultural & Forestry Univ., China (2008-2018). He has been dedicated to the development, popularisation and application of IgY Technology. Ricardo S. Vieira-Pires is an Assistant Investigator at the Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Portugal. He obtained his PhD in Structural Biology (2008) at University Joseph Fourier, Grenoble, France. He is head of the Structural Biotechnology Group that studies proteins and molecular assemblies involved in key processes of bacterial and viral infectious diseases. He is particularly interested in targeting microbial surface-exposed virulent factors using antibodies. He is head of the CNC – Avian Technological Unit that explores bird immune repertoires for antibody discovery. He is engaged with academic and industry partners promoting IgY Technology-based solutions for human and veterinary medicine. Patricia M. Morgan is an Emerita Senior Lecturer at the National University of Ireland Galway (NUI Galway). Having been awarded a PhD in Biochemistry at NUI Galway, she undertook post-doctoral research at the University of Wisconsin-Madison, USA in the areas of reproductive biology and endocrinology. She has held senior positions at NUI Galway as Dean of the College of Science and Dean of Graduate Studies. In these posts, she has championed research developments within the University particularly in the areas of Biotechnology and Innovation. She has served on various national committees promoting science and is an advocate for the public understanding of science and the promotion of inclusion and diversity in academia. Rüdiger Schade started his scientific career at the Institute of Pharmacology, Charité – Universitätsmedizin in Berlin, Germany, in 1976. Since the early 1990’s, his research has been strongly focused on the development, production and application of IgY antibodies. His contributions significantly influenced the field of IgY-technology and promoted the application of this technology worldwide, particularly in Latin-America. In acknowledgement of his research efforts, he received the FISEA prize – the International Foundation for the Substitution of Animal Experimentation, Luxemburg - in 1997. |
回复此楼» 猜你喜欢
本人考085602 化学工程 专硕
已经有6人回复
-
材料专硕326求调剂
已经有3人回复
-
311求调剂
已经有3人回复
-
东华理工大学化材专业26届硕士博士申请
已经有5人回复
-
伙伴们，祝我生日快乐吧
已经有22人回复
-
调剂
已经有7人回复
-
289求调剂
已经有5人回复
-
一志愿武理314求调剂
已经有6人回复
-
欢迎申博同学联系
已经有5人回复
-
288求调剂
已经有4人回复
» 本主题相关商家推荐: (我也要在这里推广)
» 抢金币啦！回帖就可以得到:
-
重庆医科大学神经科学中心/病生与生理系诚邀海内外优秀博士加盟博士后队伍（长期）
+1/88
-
招硕士调剂生
+2/42
-
欢迎报读澳门大学中药机制与质量研究全国重点实验室硕士研究生
+1/38
-
课题组常年招收硕士/博士研究生、博士后
+2/26
-
北京理工大学-化学与化工学院-招收2026级博士生 [申请-考核制]
+1/19
-
南京林业大学木质纤维功能材料国际联合创新中心招收2026级博士生（申请-考核制
+2/18
-
上海交通大学药学院高杨课题组诚聘博士后
+1/16
-
福建师范大学化学与材料学院杜克钊团队博士/硕士招生
+1/16
-
中国科学院苏州纳米所院士团队博士后岗位招聘
+1/15
-
教育部长江学者和创新团队发展计划”入选团队招收 材料，化学与化工博士研究生
+1/10
-
重庆大学诚招2026年生物材料方向博士生
+1/5
-
上海第二工业大学-朱大海课题组招生（过线就能调剂）
+1/5
-
海南大学徐月山老师招生第二批博士名额2~3个，2026年9月份入学（高端设备开发方向）
+1/4
-
大理大学博士招生
+1/2
-
层流压差式流量测控产品在大气运维采样流量校准中的应用与优势
+1/2
-
招收环工、环科、化工、应化、化学、生工、生物、材化等相关专业研究生，要求过国家线
+1/2
-
徐工-环境工程学院-招收调剂硕士
+1/1
-
315求调剂
+1/1
-
矿业工程招收硕士研究生
+1/1
-
339求调剂
+1/1
zzd0414112
禁虫 (正式写手)
★
vnyh3993(金币+1): 谢谢参与
vnyh3993(金币+1): 谢谢参与
|
本帖内容被屏蔽 |
4楼2021-03-15 20:35:45
简单回复
tzynew2楼
2021-03-10 15:51
回复
vnyh3993(金币+1): 谢谢参与
o 发自小木虫Android客户端
Alexpep3楼
2021-03-12 22:03
回复
vnyh3993(金币+1): 谢谢参与
2021-03-15 20:36
回复
2021-03-17 07:58
回复
vnyh3993(金币+1): 谢谢参与
7
2021-03-17 13:18
回复
vnyh3993(金币+1): 谢谢参与
nono20098楼
2021-08-26 20:15
回复
vnyh3993(金币+1): 谢谢参与
·
